Immunotherapy for the treatment of cancer gained momentum in the late 1950s with the discovery by Issacs and Linderman [35] of interferon (IFN), which displayed anti-cancer efficacy, particularly against melanoma (Figure 1). Here, IFNA1 is linked to cancer.